SHAREHOLDERS' EQUITY (Summary Of Share-Based Incentive Plan Grant Activity For Options and SAR's) (Details) - SARs - USD ($) $ / shares in Units, $ in Millions	3 Months Ended	12 Months Ended
Apr. 03, 2021	Jan. 02, 2021
Shares
Outstanding (in shares)	577,509
Granted (in shares)	112,168
Exercised (in shares)	(25,993)
Forfeited (in shares)	(12,123)
Outstanding (in shares)	651,561	577,509
Exercisable (in shares)	223,260
Weighted Average Exercise Price
Outstanding, weighted average exercise price (in dollars per share)	$ 79.35
Granted, weighted average exercise price (in dollars per share)	140.22
Exercised, weighted average exercise price (in dollars per share)	77.38
Forfeited, weighted average exercise price (in dollars per share)	86.67
Outstanding, weighted average exercise price (in dollars per share)	89.77	$ 79.35
Exercisable, weighted average exercise price (in dollars per share)	$ 75.23
Outstanding, weighted average remaining contractual term	7 years 2 months 12 days	7 years
Exercisable, weighted average remaining contractual term	4 years 9 months 18 days
Outstanding, aggregate intrinsic value	$ 36.4	$ 25.1
Exercisable, aggregate intrinsic value	$ 15.7

The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.